Foundation for innovation
in Cardiometabolism and Nutrition

Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis

Hepatology

Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis

Posted on 

ISO 9001 Certified

OUr Institutionnal Supporters

Our network